跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 118,267 条关于
“Shanghai Cancer Center”
全部
118,267
临床试验
94,473
药物
2,943
机构
2,012
资讯
18,839
7个月前
Ensem Therapeutics Expands ETX-636 Trial to China, Targeting PI3Kα Mutations in Cancer
9个月前
Chinese-Developed HER2-Targeting ADC TQB2102 Achieves 77% Complete Response Rate in Phase II Breast Cancer Trial
去年
Phase 2b Trial of Glecirasib in KRAS G12C-Mutated Non-Small-Cell Lung Cancer
去年
Novel PET Radiotracer 68Ga-FZ-NR-1 Successfully Identifies Nectin-4 Biomarker in Triple-Negative Breast Cancer Patients
去年
Antengene's Selinexor Shows Promise in Multiple Myeloma and Lymphoma Studies
去年
Innovative Therapies for HIV, Infertility, and Cancer Highlighted at CIIE
去年
Innovent Highlights IBI343 Data in Pancreatic Cancer at ESMO Asia 2024
去年
Camrelizumab Plus Chemotherapy Shows Promise in Gastric and GEJ Adenocarcinoma
去年
Alphamab Oncology's Anti-HER2 Bispecific ADC Subcutaneous Co-formulation Receives Priority Review in China
去年
Antengene to Present Selinexor Data in Relapsed/Refractory Multiple Myeloma and Extranodal NK/T-Cell Lymphoma at ASH 2024
第 1 页,共 1884 页
上一页
下一页